Will definitely grab this to pair with my ENZC portfolio!
I find it interesting how this company's Ticker "mirrors" ENZC.
What I like best about Enzo Therapeutics ENZ is 1). they have a very LOW O/S & Float; 2), are highly diversified in their products, services, and customer base; 3). trades on the NYSE; 4). has a 61% institutional ownership; and 5). an insider holding of 7.65%. That's a "winning hand" if there ever was one!
A PPS of $10 is but only one post stop on its way to a much higher trading range $100+ IMO. This one hasn't even begun to make any of its major runs yet, but it will....multiple times moving forward!
Thanks for mentioning this one. I've had my eye on it for sometime and will likely initiate a position this week and continue adding throughout 2021 along with ENZC! A DOUBLE WINNER!!
O/S: 47.9M Float: 35.17M
Current PPS: $2.03 (11/29/20) 52-Week Range 1.56 -4.85 3/18/20-3/9/20
ENZ Company Overview
Enzo Biochem, Inc. is a Bioscience company focusing on delivering and applying technology capabilities to produce products and services.
The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies.
It offers a menu of molecular and other clinical laboratory tests or procedures. Enzo Life Sciences manufactures, develops and markets products and tools to clinical research, drug development, and Bioscience research customers.
Enzo Therapeutics is a Bio-Pharmaceutical venture that develops multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases. Its products in the development pipeline include a range of assays for detection of various women's health infectious agents, as well as for use in the identification of pathogens for other markets.
News 
Market Data 
Discover 
